Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Anabel Jimenez Millan"'
Autor:
Beatriz Aviles Bueno, Maria Jose Soler, Luis Perez-Belmonte, Anabel Jimenez Millan, Francisco Rivas Ruiz, Maria Dolores Garcia de Lucas
Publikováno v:
Scientia
Background Semaglutide [glucagon-like peptide-1 receptor-agonist (GLP-1RA)] has shown nephroprotective effects in previous cardiovascular studies. However, its efficacy and safety in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcdafecdd8a34421079b6813377e0e34
https://doi.org/10.1093/ckj/sfac096
https://doi.org/10.1093/ckj/sfac096
Autor:
Bueno, Beatriz Aviles1 (AUTHOR) avilesbb@hotmail.com, Soler, Maria Jose2 (AUTHOR), Perez-Belmonte, Luis3 (AUTHOR), Millan, Anabel Jimenez4 (AUTHOR), Ruiz, Francisco Rivas5 (AUTHOR), Lucas, Maria Dolores Garcia de6 (AUTHOR)
Publikováno v:
Clinical Kidney Journal. Aug2022, Vol. 15 Issue 8, p1593-1600. 8p.
Publikováno v:
Clinical Trials Week; 3/11/2024, p892-892, 1p